PTS Diagnostics

PTS Diagnostics is a point-of-care diagnostics manufacturing company committed to the betterment of chronic disease management and closure of gaps in care through point-of-care delivery, customer focus, innovative technology, and adherence to robust quality standards. 

PTS Diagnostics’ signature products include the CardioChek® lipid analyzer, and the A1CNow® family of products. The CardioChek® family of products have screened more than 120 million patients worldwide while the A1CNow® product line works to enable people to lead healthier lives through ongoing management of diabetes. Together these products help identify individuals with cardiometabolic syndrome, a cluster of conditions that increase risks of developing cardiovascular disease or diabetes.

Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, and markets products for distribution in hundreds of countries around the world.  The company has manufacturing facilities in Indianapolis, IN, and Sunnyvale, CA, and has sales offices in North America, Europe, Latin America, and the Pacific Rim.

PTS Diagnostics is innovating point-of-care with people, technology and service.